CANTEL MEDICAL CORP (CMN) is a publicly traded company in the Unknown sector. Across all available filings, 22 corporate insiders have executed 1000 transactions totaling $48.0M, demonstrating a bearish sentiment with -$47.8M in net insider flow. The most recent transaction on Oct 10, 2019 involved a transaction of 145 shares valued at $10.0K.
No significant insider buying has been recorded for CMN in the recent period.
No significant insider selling has been recorded for CMN in the recent period.
Based on recent SEC filings, insider sentiment for CMN is bearish with an Insider Alignment Score of 0/100 and a net flow of -$47.8M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at CANTEL MEDICAL CORP (CMN) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 22 insiders are actively trading CMN stock, having executed 1000 transactions in the past 90 days. The most active insider is Charles M. Diker (Executive), who has made 165 transactions totaling $22.1M.
Get notified when executives and directors at CMN file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Oct 10, 2019 | Z. Mann Jeffrey | Executive | Payment | 145 | $68.89 | $10.0K | |
| Oct 10, 2019 | Z. Mann Jeffrey | Executive | Award | 3,630 | $N/A | $0 | |
| Oct 10, 2019 | M. Yellin Seth | Executive | Payment | 1,111 | $68.89 | $76.5K | |
| Oct 10, 2019 | M. Yellin Seth | Executive | Award | 3,025 | $N/A | $0 | |
| Oct 10, 2019 | M. Yellin Seth | Executive | Disposition | 299 | $N/A | $0 | |
| May 16, 2019 | M. Yellin Seth | Executive | Award | 7,425 | $N/A | $0 | |
| Oct 16, 2018 | M. Yellin Seth | Executive | Payment | 141 | $85.33 | $12.0K | |
| Oct 12, 2018 | M. Yellin Seth | Executive | Payment | 513 | $84.82 | $43.5K | |
| Oct 10, 2018 | M. Yellin Seth | Executive | Award | 2,355 | $N/A | $0 | |
| Oct 10, 2018 | M. Yellin Seth | Executive | Award | 877 | $N/A | $0 | |
| Oct 10, 2018 | M. Yellin Seth | Executive | Payment | 726 | $88.42 | $64.2K | |
| Oct 16, 2017 | M. Yellin Seth | Executive | Payment | 442 | $96.46 | $42.6K | |
| Oct 12, 2017 | M. Yellin Seth | Executive | Payment | 555 | $95.07 | $52.8K | |
| Oct 12, 2017 | M. Yellin Seth | Executive | Payment | 555 | $95.07 | $52.8K | |
| Oct 10, 2017 | M. Yellin Seth | Executive | Award | 1,880 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 291 | $47.9M | 53.4% |
Payment(F) | 208 | $25.0M | 27.9% |
Exercise(M) | 164 | $15.0M | 16.7% |
Award(A) | 126 | $1.7M | 1.9% |
Purchase(P) | 13 | $87.5K | 0.1% |
Disposition(D) | 1 | $0 | 0.0% |
Gift(G) | 187 | $0 | 0.0% |
Other(J) | 10 | $0 | 0.0% |
Insider selling pressure at CANTEL MEDICAL CORP has increased, with 22 insiders executing 1000 transactions across all time. Total sales of $47.9M significantly outpace purchases of $87.5K, resulting in a net outflow of $47.8M. This selling activity appears largely discretionary, which may warrant closer attention from investors.